TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in TFF Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −4 vs. Q4 2023
- Shares held
- 350.9K
- +1.48K (+0.4%) vs. Q4 2023
- Total value
- $2.12M
- −$329.5K (−13.4%) vs. Q4 2023
- New holders
- 1
- 7 more added
- Sold out
- 5
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TFFP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 3 | $0 |
| Q4 2024 | 4 | $196 |
| Q3 2024 | 23 | $1.48M |
| Q2 2024 | 21 | $1.07M |
| Q1 2024 | 19 | $2.12M |
| Q4 2023 | 23 | $2.45M |
| Q3 2023 | 41 | $4.04M |
| Q2 2023 | 33 | $3.02M |
| Q1 2023 | 36 | $4.80M |
| Q4 2022 | 41 | $7.52M |
| Q3 2022 | 45 | $17.2M |
| Q2 2022 | 45 | $23.7M |
| Q1 2022 | 43 | $27.1M |
| Q4 2021 | 51 | $41.1M |
| Q3 2021 | 54 | $45.1M |
| Q2 2021 | 60 | $54.5M |
| Q1 2021 | 63 | $96.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding TFF Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlson Capital L P | 193,960 | $1.17M | 0.10% | 00.0% | Unchanged |
| DRW Securities, LLC | 40,000 | $241.6K | 0.01% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 39,225 | $236.9K | 0.06% | +31,089+382.1% | Added |
| Vanguard Group Inc | 34,743 | $209.8K | 0.00% | +870+2.6% | Added |
| Geode Capital Management, LLC | 17,343 | $107.4K | 0.00% | +1,623+10.3% | Added |
| Renaissance Technologies LLC | 13,198 | $80.0K | 0.00% | +1,701+14.8% | Added |
| BlackRock Inc. | 7,799 | $47.1K | 0.00% | −728−8.5% | Reduced |
| University of Texas/Texas Am Investment Managment Co | 1,764 | $11.5K | 0.00% | +882+100.0% | Added |
| UBS Group AG | 1,127 | $6.81K | 0.00% | −686−37.8% | Reduced |
| Tower Research Capital LLC (TRC) | 502 | $3.03K | 0.00% | −870−63.4% | Reduced |
| Royal Bank of Canada | 487 | $3.00K | 0.00% | +178+57.6% | Added |
| Newbridge Financial Services Group, Inc. | 434 | $2.62K | 0.00% | −918−67.9% | Reduced |
| Gen-Wealth Partners Inc | 100 | $604 | 0.00% | +100 | New |
| Wells Fargo & Company | 78 | $471 | 0.00% | +1+1.3% | Added |
| HM Payson & Co | 60 | $363 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 40 | $241 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 35 | $211 | 0.00% | −57−62.0% | Reduced |
| Morgan Stanley | 32 | $193 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5 | $31 | 0.00% | −1,065−99.5% | Reduced |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −29,482−100.0% | Sold out |
| ORG Partners LLC | 0 | $0 | 0.00% | −740−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −330−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |